It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.
Related Posts
How multifamily offices are playing commercial real estate
With more than $12 billion under management, Realm is a multifamily office investment platform specializing in commercial real estate.
Airlines’ wild 2024: From Boeing troubles to a bankruptcy and a merger
The U.S. airline industry had another busy year while strong demand buoyed stocks into the end of the year.
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.